Top

Cancer and Metastasis Reviews

Published in:

01-03-2021 | Shingles | EDITORIAL

Potential late effects of SARS-CoV-2 (COVID-19) infection: parallels to cancer late effects

Authors: Richard P. Phipps, Patricia J. Sime, Connor R. Phipps

Published in: Cancer and Metastasis Reviews | Issue 1/2021

Excerpt

“Corona virus: a simple pathogen causing complex disease. Will there be dangerous late effects in the years ahead?”

…

Klonoff-Cohen, H., & Polavarapu, M. (2020). Existence of late-effects instruments for cancer survivors: A systematic review. PloS one, 15(2), e0229222. https://doi.org/10.1371/journal.pone.0229222.CrossRefPubMedPubMedCentral

Panigrahy, D., Gilligan, M. M., Huang, S., Gartung, A., Cortés-Puch, I., Sime, P. J., Phipps, R. P., Serhan, C. N., & Hammock, B. D. (2020). Inflammation resolution: A dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev, 39(2), 337–340. https://doi.org/10.1007/s10555-020-09889-4.CrossRefPubMed

Ghaebi, M., Osali, A., Valizadeh, H., Roshangar, L., & Ahmadi, M. (2020). Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances. J Cell Physiol, 235(12), 9098–9109. https://doi.org/10.1002/jcp.29771.CrossRefPubMed

Title: Potential late effects of SARS-CoV-2 (COVID-19) infection: parallels to cancer late effects
Authors: Richard P. Phipps
Patricia J. Sime
Connor R. Phipps
Publication date: 01-03-2021
Publisher: Springer US
Keywords: Shingles
SARS-CoV-2
COVID-19
Published in: Cancer and Metastasis Reviews / Issue 1/2021
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-021-09954-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review

Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?

An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression

Beyond tradition and convention: benefits of non-traditional model organisms in cancer research

Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?

Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer